83 FR 12081 - Proposed Collection; Comment Request for Form 8820.

DEPARTMENT OF THE TREASURY
Internal Revenue Service

Federal Register Volume 83, Issue 53 (March 19, 2018)

The Internal Revenue Service, as part of its continuing effort to reduce paperwork and respondent burden, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995. The IRS is soliciting comments concerning Form 8820, Orphan Drug Credit.

[Federal Register Volume 83, Number 53 (Monday, March 19, 2018)]
[Notices]
[Page 12081]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-05518]


-----------------------------------------------------------------------

DEPARTMENT OF THE TREASURY

Internal Revenue Service


Proposed Collection; Comment Request for Form 8820.

AGENCY: Internal Revenue Service (IRS), Treasury.

ACTION: Notice and request for comments.

-----------------------------------------------------------------------

SUMMARY: The Internal Revenue Service, as part of its continuing effort 
to reduce paperwork and respondent burden, invites the general public 
and other Federal agencies to take this opportunity to comment on 
proposed and/or continuing information collections, as required by the 
Paperwork Reduction Act of 1995. The IRS is soliciting comments 
concerning Form 8820, Orphan Drug Credit.

DATES: Written comments should be received on or before May 18, 2018 to 
be assured of consideration.

ADDRESSES: Direct all written comments to Laurie Brimmer, Internal 
Revenue Service, Room 6526, 1111 Constitution Avenue NW, Washington, DC 
20224.

FOR FURTHER INFORMATION CONTACT: Requests for additional information or 
copies of the form and instructions should be directed to Sara 
Covington at Internal Revenue Service, Room 6526, 1111 Constitution 
Avenue NW, Washington, DC 20224, or at (202) 317-6038 or through the 
internet at [email protected].

SUPPLEMENTARY INFORMATION: 
    Title: Orphan Drug Credit.
    OMB Number: 1545-1505.
    Form Number: 8820.
    Abstract: Filers use this form to elect to claim the orphan drug 
credit, which is 50% of the qualified clinical testing expenses paid or 
incurred with respect to low or unprofitable drugs for rare diseases 
and conditions, as designated under section 526 of the Federal Food, 
Drug, and Cosmetic Act.
    Current Actions: There are no changes being made to the form at 
this time.
    Type of Review: Extension of a currently approved collection.
    Affected Public: Business or other for-profit organizations.
    Estimated Number of Respondents: 67.
    Estimated Time per Respondent: 5 hours, 12 minutes.
    Estimated Total Annual Burden Hours: 348.
    The following paragraph applies to all of the collections of 
information covered by this notice:
    An agency may not conduct or sponsor, and a person is not required 
to respond to, a collection of information unless the collection of 
information displays a valid OMB control number. Books or records 
relating to a collection of information must be retained as long as 
their contents may become material in the administration of any 
internal revenue law. Generally, tax returns and tax return information 
are confidential, as required by 26 U.S.C. 6103.
    Request for Comments: Comments submitted in response to this notice 
will be summarized and/or included in the request for OMB approval. All 
comments will become a matter of public record. Comments are invited 
on: (a) Whether the collection of information is necessary for the 
proper performance of the functions of the agency, including whether 
the information shall have practical utility; (b) the accuracy of the 
agency's estimate of the burden of the collection of information; (c) 
ways to enhance the quality, utility, and clarity of the information to 
be collected; (d) ways to minimize the burden of the collection of 
information on respondents, including through the use of automated 
collection techniques or other forms of information technology; and (e) 
estimates of capital or start-up costs and costs of operation, 
maintenance, and purchase of services to provide information.

    Approved: March 13, 2018.
Laurie Brimmer,
Senior Tax Analyst.
[FR Doc. 2018-05518 Filed 3-16-18; 8:45 am]
 BILLING CODE 4830-01-P